Diseases of large and small joints, as a rule, are associated with changes in the dystrophic character in the cartilaginous tissue. Over time, it collapses, determining the stage of the disease. Chondroprotectors of the new generation slow down the process of abrasion of the cartilaginous tissue, and also contribute to the improvement of joint nutrition, the growth of new healthy cells.
Chondroprotectors for joints of new generation
First, let's look at the differences between the described drugs and their earlier counterparts.
Chondroprotectors of the first generation provoke the production of hyaluronic acid and collagen by cells of cartilaginous tissue. Due to this, it does not collapse so quickly, and even in the mild stages of the diseases of the musculoskeletal system it is even restored. To date, only Alflutop is used.
The second generation of medications has a more pronounced effect and a stable result. In addition, this variety of drugs contains chondroitin sulfate and glucosamine hydrochloride. These active substances not only stimulate collagen fibers and the production of elastin, but also improve the course of metabolic processes in the hyaline tissue, help to stop inflammation, relieve pain.
The newest chondroprotectors are a combination of drugs of the previous (second) generation and nonsteroidal anti-inflammatory ingredients. Thanks to such a combination, the preparations allow achieving stable and stable improvement of cartilage tissue functions, its restoration, and at the same time to reduce pain sensations and inflammatory processes in the shortest possible time. Moreover, third-generation medicines have the least side effects with respect to the urinary, food and cardiovascular system, since the correct ratio of active ingredients ensures a mutual reduction in their toxicity.
Chondroprotectors of the new generation in osteochondrosis, arthrosis and arthritis
The described medications are usually available in capsules for systemic administration.
Conditionally they can be divided into groups:
1. Preparations in combination with methylsulfonylmethane:
- Arthron;
- Triac.
2. Medicines with vitamin constituents and growth stimulators of cartilage tissue:
- Arthron Complex;
- Chondroitin Complex.
3. Medications with diclofenac or ibuprofen:
- Advance;
- Movex;
- Teraflex.
As medical practice shows, the listed combined agents have many advantages:
- pronounced and long-term therapeutic effect;
- good tolerability;
- minimum number of side effects;
- improvement of metabolism in cartilaginous tissue;
- relief of pain syndrome, which allows completely canceling the intake of additional non-steroidal anti-inflammatory drugs;
- increased bone density;
- reduced risk of complications;
- restoration of the structure and metabolism in the damaged cartilage;
- stimulation of chondrocyte formation.
Chondroprotectors of the new generation in injections
With clearly expressed clinical manifestations of cartilage diseases, a strong pain syndrome, new generation chondroprotectors are used in injections, which are injected directly into the diseased joint or intramuscularly.
The best medicines are:
- Elbon;
- Don;
- Chondrolon;
- Rumalon;
- Artradol.
It is also worth noting that preparations of hyaluronic acid and collagen , for example, Alflutop, are still effective. In addition, orthopedists recommend entering into the cartilage an artificial periarticular fluid:
- Fermatron;
- A syncope;
- Hyastat.